Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis
Top Cited Papers
Open Access
- 30 December 2008
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 60 (1) , 225-233
- https://doi.org/10.1002/art.24183
Abstract
Objective There is now growing evidence that connective tissue diseases, including systemic sclerosis (SSc), share a common genetic background. Microarray studies support a pivotal role of type I interferon (IFN) in the pathophysiology of connective tissue diseases. Interferon regulatory factors coordinate the expression of type I IFNs, and the IRF5 gene has been identified as a susceptibility gene of systemic lupus and Sjögren's syndrome. The aim of this study was to determine whether the IRF5 rs2004640 single-nucleotide polymorphism is associated with SSc. Methods The IRF5 rs2004640 (GT) functional polymorphism was genotyped in 1,641 subjects of French European Caucasian origin: a discovery set comprising 427 patients with SSc and 380 control subjects and a replication set comprising 454 patients with SSc and 380 control subjects. Results In both the discovery set and the replication set, the TT genotype was significantly more common in patients with SSc than in control subjects, with an odds ratio (OR) for the combined populations of 1.58 (95% confidence interval [95% CI] 1.18–2.11 [P for trend 0.002]). Analyses of the whole SSc population showed a significant association between homozygosity for the T allele and the presence of antinuclear antibodies (corrected P [Pcorr] = 0.04, OR 1.59, 95% CI 1.16–2.17) and fibrosing alveolitis (Pcorr = 0.001, OR 2.07, 95% CI 1.38–3.11). In a multivariate analysis model including the diffuse cutaneous subtype of SSc and positivity for anti–topoisomerase I antibodies, the IRF5 rs2004640 TT genotype remained associated with fibrosing alveolitis (P = 0.029, OR 1.92, 95% CI 1.07–3.44). Conclusion The IRF5 rs2004640 GT substitution is associated with susceptibility to SSc. These data provide new insight into the pathogenesis of SSc, including clues to the mechanisms leading to fibrosing alveolitis.This publication has 25 references indexed in Scilit:
- Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?Annals of the Rheumatic Diseases, 2009
- The PTPN22 620W allele confers susceptibility to systemic sclerosis: Findings of a large case–control study of European Caucasians and a meta‐analysisArthritis & Rheumatism, 2008
- Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populationsJournal of Medical Genetics, 2008
- Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?PLOS ONE, 2008
- Association of an IRF5 gene functional polymorphism with Sjögren's syndromeArthritis & Rheumatism, 2007
- Three functional variants of IFN regulatory factor 5 ( IRF5 ) define risk and protective haplotypes for human lupusProceedings of the National Academy of Sciences, 2007
- Toll-like receptors and innate immune responses in systemic lupus erythematosusArthritis Research & Therapy, 2007
- Association of the PTPN22 R620W polymorphism with anti–topoisomerase I– and anticentromere antibody–positive systemic sclerosisArthritis & Rheumatism, 2006
- Computing power in case‐control association studies through the use of quadratic approximations: application to meta‐statisticsAnnals of Human Genetics, 2006
- Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patientsRheumatology, 2006